Drugs Made In America Acquisition II Corp. Unit Company Profile
NASDAQ: DMIIUUSD
10.23-0.0199 (-0.19%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Drugs Made In America Acquisition II Unit at a glance
Drugs Made In America Acquisition II Corp. Unit (NASDAQ: DMIIU) is a publicly traded company headquartered in New York, NY. The company's shares have traded publicly since 2025. Its SEC Central Index Key (CIK) is 0002040475, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Drugs Made In America Acquisition II Corp. Unit
- Ticker
- NASDAQ: DMIIU
- Headquarters
- 420 Lexington Avenue, Suite 1402 10170, New York, NY, United States
- Phone
- 954-870-3104
- IPO year
- 2025
- SEC CIK
- 0002040475
- Latest annual report
- 10-K · Apr 15, 2026